Altimmune Inc (ALT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
8.19%
26.23
|
24.24 | 28.92 | 20.86 | 22.93 |
| Operating Income/Loss |
8.19%
-26.23
|
-24.24 | -28.89 | -20.86 | -22.92 |
| Nonoperating Income/Loss |
102.50%
3.404
|
1.681 | 1.535 | 1.845 | 0.776 |
| Income/Loss From Continuing Operations Before Tax |
1.16%
-22.82
|
-22.56 | -27.36 | -19.01 | -22.15 |
| Net Income/Loss |
1.16%
-22.82
|
-22.56 | -27.36 | -19.01 | -22.15 |
| Basic Average Shares |
49.00%
185.44
|
124.46 | 5.9056 | 89.42 | 81.48 |
| Diluted Average Shares |
49.00%
185.44
|
124.46 | 5.9056 | 89.42 | 81.48 |
| Basic Earnings Per Share |
33.33%
-0.12
|
-0.18 | -0.26 | -0.21 | -0.27 |
| Diluted Earnings Per Share |
33.33%
-0.12
|
-0.18 | -0.26 | -0.21 | -0.27 |
자본화:
|
볼륨(24시간):